BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9463789)

  • 21. Malignant pleural effusions: management options with consideration of coding, billing, and a decision approach.
    Haas AR; Sterman DH; Musani AI
    Chest; 2007 Sep; 132(3):1036-41. PubMed ID: 17873197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging paradigms in the management of malignant pleural effusions.
    Khaleeq G; Musani AI
    Respir Med; 2008 Jul; 102(7):939-48. PubMed ID: 18356033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions.
    Hartman DL; Gaither JM; Kesler KA; Mylet DM; Brown JW; Mathur PN
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):743-7; discussion 747-8. PubMed ID: 7682268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis.
    Marom EM; Patz EF; Erasmus JJ; McAdams HP; Goodman PC; Herndon JE
    Radiology; 1999 Jan; 210(1):277-81. PubMed ID: 9885620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of malignant pleural effusions.
    Heffner JE
    Respirology; 2008 Jan; 13(1):5-20. PubMed ID: 18197908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of pleurodesis.
    Rodriguez-Panadero F; Montes-Worboys A
    Respiration; 2012; 83(2):91-8. PubMed ID: 22286268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of malignant pleural effusions.
    Spector M; Pollak JS
    Semin Respir Crit Care Med; 2008 Aug; 29(4):405-13. PubMed ID: 18651358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of malignant pleural effusion secondary to breast cancer: talc pleurodesis and pleuroperitoneal shunting.
    Saute M
    Isr J Med Sci; 1995; 31(2-3):160-2. PubMed ID: 7744586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pleural effusions: pathophysiology and management.
    Andrews CO; Gora ML
    Ann Pharmacother; 1994; 28(7-8):894-903. PubMed ID: 7524816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant pleural diseases.
    Rodriguez-Panadero F
    Monaldi Arch Chest Dis; 2000 Feb; 55(1):17-9. PubMed ID: 10786419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions to treat malignant pleural effusions.
    Lenker A; Mayer DK; Bernard SA
    Clin J Oncol Nurs; 2015 Oct; 19(5):501-4. PubMed ID: 26414568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of malignant pleural effusions: questions that need answers.
    Davies HE; Lee YC
    Curr Opin Pulm Med; 2013 Jul; 19(4):374-9. PubMed ID: 23673450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is the best treatment for malignant pleural effusions?
    Zahid I; Routledge T; Billè A; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):818-23. PubMed ID: 21325469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
    Kolschmann S; Ballin A; Gillissen A
    Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial.
    Haddad FJ; Younes RN; Gross JL; Deheinzelin D
    World J Surg; 2004 Aug; 28(8):749-53; discussion 753-4. PubMed ID: 15457352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pleural controversy: pleurodesis versus indwelling pleural catheters for malignant effusions.
    MacEachern P; Tremblay A
    Respirology; 2011 Jul; 16(5):747-54. PubMed ID: 21545373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.
    Das SK; Saha SK; Das A; Halder AK; Banerjee SN; Chakraborty M
    J Indian Med Assoc; 2008 Sep; 106(9):589-90, 592. PubMed ID: 19552086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
    Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
    Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pleural malignancies.
    Vargas FS; Teixeira LR
    Curr Opin Pulm Med; 1996 Jul; 2(4):335-40. PubMed ID: 9363162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pleurodesis in malignant pleural effusion].
    Bronner GM; Baas P; Beijnen JH
    Ned Tijdschr Geneeskd; 1997 Sep; 141(38):1810-4. PubMed ID: 9545735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.